Sorry, you need to enable JavaScript to visit this website.
Skip to main content

Monographs Affected by Revision to General Chapter <191> Identification Tests – General

Type of Posting: Reference Changes

Posting Date: 16–Mar–2015

Targeted Official Date: 01–May–2017

Expert Committee: General Chapters—Chemical Analysis

In accordance with section 7.05(c) of the 2010–2015 Rules and Procedures of the Council of Experts, this is to provide notice that USP and its Expert Committees, as applicable, intend to revise multiple monographs in response to the revision of General Chapter <191> Identification Tests – General. General Chapter <191> is being revised to be consistent with USP’s effort to modernize monographs and General Chapters.

General Chapter <191> will be published in Pharmacopeial Forum (PF) 41(2) [Mar.–Apr. 2015]. Comments will be accepted until May 31, 2015, the end of the comment period for PF 41(2).

The changes will be incorporated in the First Supplement to USP 39–NF 34 when the revision of General Chapter <191> becomes official. In the meantime, interested parties are encouraged to submit comments on this proposal. Should you have any questions or comments, please contact Antonio Hernandez-Cardoso, Senior Scientific Liaison, General Chapters at (301) 816-8308 or ahc@usp.org.

USP will coordinate General Chapter <191> and the affected monographs so that they become official at the same time.

USP has identified the following monographs that reference General Chapter <191> and thus require some degree of revision:

  • Alendronate Sodium
  • Aminobenzoate Potassium
  • Aminobenzoate Sodium
  • Aminohippurate Sodium Injection
  • Ascorbic Acid Injection
  • Barium Hydroxide Lime
  • Calcium Propionate
  • Croscarmellose Sodium
  • Dantrolene Sodium
  • Diatrizoate Sodium
  • Diclofenac Potassium
  • Diclofenac Potassium Tablets
  • Diclofenac Sodium
  • Diclofenac Sodium Delayed-Release Tablets
  • Dihydroxyaluminum Sodium Carbonate
  • Docusate Potassium
  • Edetate Disodium
  • Etidronate Disodium
  • Half-Strength Lactated Ringer's And Dextrose Injection
  • Heparin Sodium
  • Hydrocortisone Sodium Succinate
  • Iodine Tincture
  • Iodine Topical Solution
  • Iothalamate Sodium Injection
  • Ipodate Sodium
  • Ipodate Sodium Capsules
  • Lactated Ringer's And Dextrose Injection
  • Lactated Ringer's Injection
  • Levothyroxine Sodium
  • Mesna
  • Methylprednisolone Sodium Succinate
  • Modified Lactated Ringer's And Dextrose Injection
  • Multiple Electrolytes And Dextrose Injection Type 1
  • Multiple Electrolytes And Dextrose Injection Type 2
  • Multiple Electrolytes And Dextrose Injection Type 3
  • Multiple Electrolytes And Dextrose Injection Type 4
  • Multiple Electrolytes And Invert Sugar Injection Type 1
  • Multiple Electrolytes And Invert Sugar Injection Type 2
  • Multiple Electrolytes And Invert Sugar Injection Type 3
  • Multiple Electrolytes Injection Type 1
  • Multiple Electrolytes Injection Type 2
  • Mupirocin Calcium
  • Oral Rehydration Salts
  • Penicillin G Potassium
  • Penicillin V Potassium
  • Phenytoin Sodium
  • Potassium Benzoate
  • Potassium Chloride In Dextrose And Sodium Chloride Injection
  • Potassium Chloride In Dextrose Injection
  • Potassium Chloride In Lactated Ringer's And Dextrose Injection
  • Potassium Chloride In Sodium Chloride Injection
  • Potassium Gluconate
  • Potassium Gluconate Oral Solution
  • Potassium Gluconate Tablets
  • Prompt Phenytoin Sodium Capsules
  • Ringer's And Dextrose Injection
  • Ringer's Injection
  • Risedronate Sodium
  • Secobarbital Sodium And Amobarbital Sodium Capsules
  • Secobarbital Sodium Injection
  • Sodium Cetostearyl Sulfate
  • Sodium Chloride And Dextrose Tablets
  • Sodium Citrate And Citric Acid Oral Solution
  • Sodium Hypochlorite Solution
  • Sodium Nitroprusside
  • Sodium Salicylate Tablets
  • Strong Iodine Tincture
  • Tribasic Calcium Phosphate
  • Warfarin Sodium